Cargando…
Beyond PI3Ks: targeting phosphoinositide kinases in disease
Lipid phosphoinositides are master regulators of almost all aspects of a cell’s life and death and are generated by the tightly regulated activity of phosphoinositide kinases. Although extensive efforts have focused on drugging class I phosphoinositide 3-kinases (PI3Ks), recent years have revealed o...
Autores principales: | Burke, John E., Triscott, Joanna, Emerling, Brooke M., Hammond, Gerald R. V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663198/ https://www.ncbi.nlm.nih.gov/pubmed/36376561 http://dx.doi.org/10.1038/s41573-022-00582-5 |
Ejemplares similares
-
Crucial Players for Inter-Organelle Communication: PI5P4Ks and Their Lipid Product PI-4,5-P(2) Come to the Surface
por: Ravi, Archna, et al.
Publicado: (2022) -
Inhibitors of phosphoinositide 3-kinase (PI3K) and phosphoinositide 3-kinase-related protein kinase family (PIKK)
por: Huang, Xueqin, et al.
Publicado: (2023) -
Targeting phosphoinositide signaling in cancer: relevant techniques to study lipids and novel avenues for therapeutic intervention
por: Llorente, Alicia, et al.
Publicado: (2023) -
Class I PI3Ks in arterial thrombosis
por: Laurent, Pierre-Alexandre, et al.
Publicado: (2019) -
Targeting phosphoinositide 3-kinase (PI3K) in head and neck squamous cell carcinoma (HNSCC)
por: Jung, Kyungsuk, et al.
Publicado: (2018)